Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voraxaze with HD-MTX in CNS Lymphoma with Renal Impairment
NCT04841434Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2021
- Primary completion
- Dec 2024
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucarpidase in central nervous system lymphoma, sponsored by Charité – Universitätsmedizin Berlin. Started Jun 2021; status: completed.
02
Drugs
glucarpidase
03
Conditions
central nervous system lymphoma
Beyond the preview
Go deeper on NCT04841434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04841434.